Key Medicare Changes in 2026: Price Increases and Grocery Benefits changes from CMS

As we look ahead to 2026, significant changes are coming for Medicare beneficiaries. The Centers for Medicare & Medicaid Services (CMS) has announced updates that will impact costs, benefits, and prescription drug pricing. Understanding these changes is crucial for beneficiaries to navigate their healthcare options effectively. This blog post will explore the key changes, including price increases, grocery benefit modifications, and negotiated prescription drug prices.

A grocery cart filled with fresh produce, symbolizing the new grocery benefits in Medicare 2026

1. Price Increases in Medicare Part B

The Medicare Part B monthly premium is $185.00 in 2025 and is projected to increase to $206.50 in 2026, an 11.6% jump, which represents the largest dollar increase in four years. This projected 2026 premium is based on estimates from the Medicare Trustees' Report. Higher-income beneficiaries will pay even more due to the Income-Related Monthly Adjustment Amount (IRMAA), which is also expected to rise in 2026. 

Factors Driving the 2026 Increase

Several factors are contributing to the projected rise in Part B premiums for 2026: 

• Healthcare Inflation: Increased costs for medical services and hospital care are a primary driver. 

• Utilization Growth: More people are using outpatient services and preventive screenings. 

• Program Adjustments: Anticipated changes and considerations for Medicare's trust funds are also playing a role. 

2. Changes to Grocery Benefits

In 2026, traditional grocery allowances in Medicare Advantage plans will likely be replaced or restricted, shifting from the prior Value-Based Insurance Design (VBID) program to the Special Supplemental Benefits for the Chronically Ill (SSBCI) program. Under the SSBCI, only healthy food can be offered, and the benefits must be directly tied to managing a specific chronic condition, rather than generic discounts or allowances for general groceries. Therefore, some plans that offered utility or general food credits may discontinue them, while others may continue offering healthy food benefits to eligible chronically ill members with specific health needs. 

Why the Change?

• The VBID model, which supported these benefits, is ending.

• CMS has established new rules for SSBCI benefits, including a list of prohibited items like non-healthy food, alcohol, and tobacco.

• The focus has shifted to requiring benefits to be directly relevant to a chronic illness and have a reasonable expectation of improving health or function. 

What to Expect in 2026:

• Healthy Food Focus: Plans can continue to offer healthy food benefits, but only for eligible members with chronic conditions. 

• Non-Healthy Food Banned: Benefits that cover non-healthy foods (like candy or soda) will be excluded. 

• Check Your Plan's Letter: If you have a Medicare Advantage plan, your plan must send an Annual Notice of Change letter before the Annual Enrollment Period starts on October 15th. This letter will provide specific details about any benefit changes for 2026. 

• Individual Plan Variations: Some plans may find it easier to comply with the new rules than others, leading to variations in benefits from plan to plan. 

3. Negotiated Prescription Drug Prices

In 2026, the Centers for Medicare & Medicaid Services (CMS) will introduce negotiated prices for the first 10 Medicare Part D medications, including well-known treatments like Eliquis, Xarelto, Januvia, Jardiance, and Enbrel. These negotiated prices, effective January 1, 2026, offer significant discounts from the original list prices, potentially saving Medicare billions of dollars. The selected drugs are among those with the highest Part D gross costs and are used by millions of Medicare beneficiaries to treat conditions such as cardiovascular disease, diabetes, cancer, and rheumatoid arthritis. 

• Discounted Prices: In the initial round of negotiations, discounts on the negotiated prices ranged from 38% to 79% compared to the drugs' list prices. 

• Growing Scope: The number of drugs chosen for negotiation will expand in the coming years. CMS plans to select up to 15 additional drugs for 2027, another 15 for 2028, and 20 for 2029 and beyond. 

• Impact: The aim of negotiating these prices is to lower prescription drug costs for both Medicare enrollees and the Medicare program itself. 

• Negotiation Process: CMS conducted a multi-step negotiation process with each drug manufacturer, taking into account factors like research and development expenses, production costs, and market data to agree on a mutually acceptable price. 

• Official Information: For further details, including specific negotiated prices and manufacturer information, refer to resources from the Centers for Medicare & Medicaid Services (CMS)

5. Preparing for the Changes

As 2026 approaches, beneficiaries should take proactive steps to prepare for the upcoming changes. Here are a few practical tips to help:

• Review Your Plan: Take the time to review your current Medicare plan so you can understand how the changes will affect your coverage and costs.

  
  

• Talk to a Medicare Broker: Keep an eye on updates from your broker and other reliable sources to stay aware of specifics regarding these changes.

  
  
  
  
  
  

Wrapping Up

The changes to Medicare in 2026, including price increases, grocery benefits modifications, and negotiated prescription drug prices, will significantly affect beneficiaries. Staying informed and prepared is key to navigating these changes successfully. By understanding the implications of these updates, beneficiaries can make educated decisions about their healthcare and financial planning.

For more detailed information, beneficiaries can visit the official CMS website or consult with their Medicare plan representatives.